Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-03-26
2000-10-03
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544284, 544286, A61K 31517, C07D23978
Patent
active
061273759
ABSTRACT:
The present invention relates to 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinthiones of formula I: ##STR1## or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
REFERENCES:
patent: 3660322 (1972-05-01), Bernardi et al.
patent: 5519021 (1996-05-01), Young et al.
Huffman et al., J. Org. Chem, 1995, 60, 1590-1594, "Lithium Alkoxides of Cinchona Alkaloids as Chiral Controllers for Enantioselective Acetylide Addition to Cyclic N-Acyl Ketimines".
Tucker et al., J. Med. Chem, 1994, 37, 2437-2444, "Synthesis of a Series of 4-(Arylethynyl)-6-chloro-4-cyclopropyl-3, 4-dihydroquinazolin-2 (1H)-ones as Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors".
Houpis et al., Tetrahedron Letters, 1994, 35, 6811-6814, "Synthesis of a New Generation Reverse Transcriptase Inhibitor via the BC1.sub.3 /GaCl.sub.3 -induced Condensation of Anilines with Nitriles (Sugasawa Reaction)".
Yamamoto et al., Chemical & Pharmaceutical Bulletin, 1981, 29, 8, 2135-2156, "Synthetic studies on quinazolinone derivatives. The reactions of 2-trichloro-and 2-trifluoroacetamidobenzophenones with primary amines".
Balasubramanian Venkataraman
DuPont Pharmaceuticals Company
Raymond Richard L.
LandOfFree
4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinthiones useful as does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinthiones useful as , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinthiones useful as will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-195918